Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: physiological distribution and pathological significance.
暂无分享,去创建一个
[1] T. Terada,et al. Glandular elements around the intrahepatic bile ducts in man; their morphology and distribution in normal livers. , 2008, Liver.
[2] Yasunori Sato,et al. Interaction of Toll-like receptors with bacterial components induces expression of CDX2 and MUC2 in rat biliary epithelium in vivo and in culture , 2007, Laboratory Investigation.
[3] Sanjeev Gupta,et al. Novel hepatic progenitor cell surface markers in the adult rat liver , 2007, Hepatology.
[4] P. Burgel,et al. MUC5AC, a gel-forming mucin accumulating in gallstone disease, is overproduced via an epidermal growth factor receptor pathway in the human gallbladder. , 2006, The American journal of pathology.
[5] S. Ho,et al. Cysteine-rich domains of muc3 intestinal mucin promote cell migration, inhibit apoptosis, and accelerate wound healing. , 2006, Gastroenterology.
[6] Yasunori Sato,et al. Decreased expression of Bmi1 is closely associated with cellular senescence in small bile ducts in primary biliary cirrhosis. , 2006, The American journal of pathology.
[7] Y. Nakanuma,et al. Augmented expression of hepatocytes growth factor activator inhibitor type 1 (HAI-1) in intrahepatic small bile ducts in primary biliary cirrhosis , 2006, Virchows Archiv.
[8] F. Paulsen,et al. Mucins and TFF peptides of the tear film and lacrimal apparatus. , 2006, Progress in histochemistry and cytochemistry.
[9] T. Limpaiboon,et al. Amplification of chromosome 21q22.3 harboring trefoil factor family genes in liver fluke related cholangiocarcinoma is associated with poor prognosis. , 2006, World journal of gastroenterology.
[10] S. Gendler,et al. Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice. , 2006, Gastroenterology.
[11] Y. Maehara,et al. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour , 2006, Histopathology.
[12] P. Singh,et al. RNA Interference Suppression of MUC1 Reduces the Growth Rate and Metastatic Phenotype of Human Pancreatic Cancer Cells , 2006, Clinical Cancer Research.
[13] H. Weinstein,et al. Trefoil factor family-1 mutations enhance gastric cancer cell invasion through distinct signaling pathways. , 2006, Gastroenterology.
[14] F. Paulsen,et al. Prognostic value of mucins in the classification of ampullary carcinomas. , 2006, Human pathology.
[15] W. Hoffmann. Trefoil factors , 2005, Cellular and Molecular Life Sciences CMLS.
[16] L. Thim,et al. Structure of mammalian trefoil factors and functional insights. , 2005, Cellular and molecular life sciences : CMLS.
[17] A. Giraud,et al. Multiple regulatory pathways for trefoil factor (TFF) genes. , 2005, Cellular and molecular life sciences : CMLS.
[18] L. Yin,et al. MUC1 Oncoprotein Blocks Glycogen Synthase Kinase 3β–Mediated Phosphorylation and Degradation of β-Catenin , 2005 .
[19] O. Basturk,et al. Invasive micropapillary carcinomas of the ampullo-pancreatobiliary region and their association with tumor-infiltrating neutrophils , 2005, Modern Pathology.
[20] N. Ohkohchi,et al. MUC 1 core protein as a marker of gallbladder malignancy. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[21] R. Idilman,et al. Trefoil Factor Expression in Biliary Epithelium of Graft-versus-Host Disease of the Liver after Allogeneic Hematopoietic Cell Transplantation , 2005, Transplantation.
[22] Y. Nakanuma,et al. Expression Profiles of MUC Mucin Core Protein in the Intrahepatic Biliary System : Physiological Distribution and Pathological Significance , 2005 .
[23] M. Nagino,et al. Aberrant expression of pyloric gland‐type mucin in mucin‐producing bile duct carcinomas: A clear difference between the core peptide and the carbohydrate moiety , 2005, Pathology international.
[24] S. Ito,et al. Prediction of Prognosis in Gallbladder Carcinoma by Mucin and p53 Immunohistochemistry , 2005, Digestive Diseases and Sciences.
[25] T. Tsukamoto,et al. Sox2 expression in human stomach adenocarcinomas with gastric and gastric‐and‐intestinal‐mixed phenotypes , 2005, Histopathology.
[26] T. Manabe,et al. Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct loss , 2005, The Journal of pathology.
[27] K. McGlynn,et al. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. , 2005, Gastroenterology.
[28] M. Koike,et al. Expression of homeodomain protein CDX2 in gallbladder carcinomas , 2005, Journal of Cancer Research and Clinical Oncology.
[29] Chang-Hoon Kim,et al. MUC8 as a ciliated cell marker in human nasal epithelium , 2005 .
[30] Alphonse E. Sirica,et al. Cholangiocarcinoma: Molecular targeting strategies for chemoprevention and therapy , 2005, Hepatology.
[31] S. Specht,et al. Regulation and function of trefoil factor family 3 expression in the biliary tree. , 2004, The American journal of pathology.
[32] N. LaRusso,et al. The cholangiopathies: disorders of biliary epithelia. , 2004, Gastroenterology.
[33] A. Dick,et al. Normal but not altered mucins activate neutrophils , 2004, Cell and Tissue Research.
[34] Y. Sugiyama,et al. Immunolocalization of extracellular matrix components and integrins during mouse liver development , 2004, Hepatology.
[35] N. Schaefer,et al. Carcinoma of the Ampulla of Vater: Comparative Histologic/Immunohistochemical Classification and Follow-up , 2004, The American journal of surgical pathology.
[36] Olca Basturk,et al. Pathologically and Biologically Distinct Types of Epithelium in Intraductal Papillary Mucinous Neoplasms: Delineation of an “Intestinal” Pathway of Carcinogenesis in the Pancreas , 2004, The American journal of surgical pathology.
[37] F. May,et al. The trefoil protein TFF1 is bound to MUC5AC in humangastric mucosa , 2004, Cellular and Molecular Life Sciences.
[38] Y. Jan,et al. Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis , 2004, Laboratory Investigation.
[39] D. Swallow,et al. The complete genomic organization of the human MUC6 and MUC2 mucin genes. , 2004, Genomics.
[40] Y. Nakanuma,et al. Expression of trefoil factor family 1, 2, and 3 peptide is augmented in hepatolithiasis , 2004, Peptides.
[41] D. Thornton,et al. Identification of Molecular Intermediates in the Assembly Pathway of the MUC5AC Mucin* , 2004, Journal of Biological Chemistry.
[42] G. Klöppel,et al. Differentiation pathways in duodenal and ampullary carcinomas: a comparative study on mucin and trefoil peptide expression, including gastric and colon carcinomas , 2004, Virchows Archiv.
[43] Friedrich Paulsen,et al. Human lacrimal gland mucins , 2004, Cell and Tissue Research.
[44] S. Batra,et al. Pathologic Features of Mucin-producing Bile Duct Tumors: Two Histopathologic Categories as Counterparts of Pancreatic Intraductal Papillary-mucinous Neoplasms , 2004, The American journal of surgical pathology.
[45] K. McGlynn,et al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? , 2004, Journal of hepatology.
[46] A. Poustka,et al. Site‐characteristic expression and induction of trefoil factor family 1, 2 and 3 and malignant brain tumor‐1 in normal and diseased intrahepatic bile ducts relates to biliary pathophysiology , 2004, Liver international : official journal of the International Association for the Study of the Liver.
[47] Kohzoh Imai,et al. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma‐mass forming type , 2004, Hepatology.
[48] J. Feeney,et al. Solution structure of the disulfide-linked dimer of human intestinal trefoil factor (TFF3): the intermolecular orientation and interactions are markedly different from those of other dimeric trefoil proteins. , 2003, Biochemistry.
[49] K. Tsuneyama,et al. Intrahepatic cholangiocarcinoma in cirrhosis presents granulocyte and granulocyte-macrophage colony-stimulating factor. , 2003, Human pathology.
[50] T. Irimura,et al. Expression of Different Glycoforms of Membrane Mucin (MUC1) and Secretory Mucin (MUC2, MUC5AC and MUC6) in Pancreatic Neoplasms , 2003 .
[51] Massimo Loda,et al. Silencing of CDX2 Expression in Colon Cancer via a Dominant Repression Pathway* , 2003, Journal of Biological Chemistry.
[52] K. Tsuneyama,et al. Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis. , 2003, Gastroenterology.
[53] K. Tsuneyama,et al. Aberrant Expression of Trefoil Factor Family 1 in Biliary Epithelium in Hepatolithiasis and Cholangiocarcinoma , 2003, Laboratory Investigation.
[54] K. Carraway,et al. PEA3 Transactivates the Muc4/Sialomucin Complex Promoter in Mammary Epithelial and Tumor Cells* , 2003, Journal of Biological Chemistry.
[55] A. Varki,et al. Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. , 2003, The Journal of clinical investigation.
[56] C. A. Carraway,et al. Muc4/Sialomucin Complex, the Intramembrane ErbB2 Ligand, Translocates ErbB2 to the Apical Surface in Polarized Epithelial Cells* , 2003, Journal of Biological Chemistry.
[57] A. Poustka,et al. Expression of Deleted in Malignant Brain Tumor-1 (DMBT1) Molecule in Biliary Epithelium Is Augmented in Hepatolithiasis: Possible Participation in Lithogenesis , 2003, Digestive Diseases and Sciences.
[58] N. Tanaka,et al. Hepatolithiasis--epidemiology and pathogenesis update. , 2003, Frontiers in bioscience : a journal and virtual library.
[59] G. Gores. Cholangiocarcinoma: Current concepts and insights , 2003, Hepatology.
[60] Minoru Fukuda,et al. Extended Core 1 and Core 2 Branched O-Glycans Differentially Modulate Sialyl Lewis x-type L-selectin Ligand Activity* , 2003, The Journal of Biological Chemistry.
[61] J. Neuberger,et al. Differential expression of intestinal trefoil factor in biliary epithelial cells of primary biliary cirrhosis , 2002, Hepatology.
[62] Yang Li,et al. Characterization of Human Ocular Mucin Secretion Mediated by 15(S)-HETE , 2002, Cornea.
[63] K. Imai,et al. Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: Its relationship with tumor progression and prognosis , 2002, Pathology international.
[64] S. Crawley,et al. Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas. , 2002, Gastroenterology.
[65] K. Tsuneyama,et al. Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: possible key phenomenon of hepatolithiasis. , 2002, The American journal of pathology.
[66] L. Thim,et al. Effect of trefoil factors on the viscoelastic properties of mucus gels , 2002, European journal of clinical investigation.
[67] T. Patel,et al. Worldwide trends in mortality from biliary tract malignancies , 2002, BMC Cancer.
[68] M. Kaplan,et al. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. , 2002, The Journal of clinical investigation.
[69] Tatjana Crnogorac-Jurcevic,et al. Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. , 2002, The American journal of pathology.
[70] J. Lüttges,et al. The Mucin Profile of Noninvasive and Invasive Mucinous Cystic Neoplasms of the Pancreas , 2002, The American journal of surgical pathology.
[71] Kan Yang,et al. Colorectal Cancer in Mice Genetically Deficient in the Mucin Muc2 , 2002, Science.
[72] S. Gordon,et al. Generation of ligand‐receptor alliances by “SEA” module‐mediated cleavage of membrane‐associated mucin proteins , 2002, Protein science : a publication of the Protein Society.
[73] S. Crawley,et al. MUC17, a novel membrane-tethered mucin. , 2002, Biochemical and biophysical research communications.
[74] M. Ulaganathan,et al. Biliary epithelial trefoil peptide expression is increased in biliary diseases , 2002, Histopathology.
[75] C. Reis,et al. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma , 2002, Virchows Archiv.
[76] A. Poustka,et al. Deleted in Malignant Brain Tumors 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer. , 2001, Cancer research.
[77] King-Teh Lee,et al. Altered Mucin Gene Expression in Stone-Containing Intrahepatic Bile Ducts and Cholangiocarcinomas , 2001, Digestive Diseases and Sciences.
[78] H. Adami,et al. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis , 2001, Hepatology.
[79] Y. Jan,et al. Intraductal papillary neoplasia of the liver associated with hepatolithiasis , 2001, Hepatology.
[80] I. van Seuningen,et al. Transcriptional regulation of the 11p15 mucin genes. Towards new biological tools in human therapy, in inflammatory diseases and cancer? , 2001, Frontiers in bioscience : a journal and virtual library.
[81] L. Yu,et al. Interaction between bacterial peptides, neutrophils and goblet cells: a possible mechanism for neutrophil recruitment and goblet cell depletion in colitis. , 2001, Clinical science.
[82] L. Yin,et al. The Epidermal Growth Factor Receptor Regulates Interaction of the Human DF3/MUC1 Carcinoma Antigen with c-Src and β-Catenin* , 2001, The Journal of Biological Chemistry.
[83] K. Tsuneyama,et al. Expression of MUC1 and MUC2 and carbohydrate antigen Tn change during malignant transformation of biliary papillomatosis , 2001, Histopathology.
[84] R H Hruban,et al. Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions , 2001, The American journal of surgical pathology.
[85] Y. Sugiyama,et al. Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi , 2001, Hepatology.
[86] M. Kudo. Hepatic peribiliary cysts: clinically harmless disease with potential risk due to gradual increase in size and number , 2001, Journal of Gastroenterology.
[87] Masanobu Komatsu,et al. Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor , 2001, Oncogene.
[88] R. Poulsom,et al. Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa , 2000, Gut.
[89] M. Copin,et al. Developmental Mucin Gene Expression in the Gastroduodenal Tract and Accessory Digestive Glands. II. Duodenum and Liver, Gallbladder, and Pancreas , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[90] L. Aaltonen,et al. Pathology and genetics of tumours of the digestive system , 2000 .
[91] D. Swallow,et al. Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B. , 2000, Biochemical and biophysical research communications.
[92] H. S. Kim,et al. Somatic mutations of the trefoil factor family 1 gene in gastric cancer. , 2000, Gastroenterology.
[93] N. Porchet,et al. Evolution of the large secreted gel-forming mucins. , 2000, Molecular biology and evolution.
[94] M. Hollingsworth,et al. Human MUC4 mucin cDNA and its variants in pancreatic carcinoma. , 2000, Journal of biochemistry.
[95] D. Taupin,et al. Distinct Pathways of Cell Migration and Antiapoptotic Response to Epithelial Injury: Structure-Function Analysis of Human Intestinal Trefoil Factor , 2000, Molecular and Cellular Biology.
[96] K. Chayama,et al. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus–related cirrhosis , 2000, Cancer.
[97] H. Jung,et al. Expression of Mucin Genes in Chronic Ethmoiditis , 2000, American journal of rhinology.
[98] T. Irimura,et al. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity. , 1999, Journal of biochemistry.
[99] T. Irimura,et al. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: Its relationship with a new morphological classification of cholangiocarcinoma , 1999, Hepatology.
[100] N. McNamara,et al. Control of mucin transcription by diverse injury-induced signaling pathways. , 1999, American journal of respiratory and critical care medicine.
[101] A. Corfield,et al. Secreted human conjunctival mucus contains MUC5AC glycoforms. , 1999, Glycobiology.
[102] D. Swallow,et al. Genomic organization and structure of the 3' region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin. , 1999, Biochemical and biophysical research communications.
[103] D. Gotley,et al. Two novel mucin genes down-regulated in colorectal cancer identified by differential display. , 1999, Cancer research.
[104] Y. Nakanuma,et al. Frequent expression of mucin core protein MUC1 in non-neoplastic gallbladder mucosa from patients with pancreaticobiliary maljunction. , 1999, Liver.
[105] N. Smorodinsky,et al. MUC1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel MUC1/Y protein in breast and ovarian cancer , 1999, International journal of cancer.
[106] H. Kohli,et al. CT of Liver Cysts in Patients with Autosomal Dominant Polycystic Kidney Disease , 1999, Acta radiologica.
[107] G. Stamp,et al. Trefoil factor-2, human spasmolytic polypeptide, promotes branching morphogenesis in MCF-7 cells. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[108] Y. Nakanuma,et al. Expression of MUC1 and MUC2 mucin core proteins and their messenger RNA in gall bladder carcinoma: an immunohistochemical and in situ hybridization study , 1999, The Journal of pathology.
[109] M. Hollingsworth,et al. Probiotics inhibit enteropathogenic E. coliadherence in vitro by inducing intestinal mucin gene expression. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[110] J. Wright,et al. Glycoprotein-340 binds surfactant protein-A (SP-A) and stimulates alveolar macrophage migration in an SP-A-independent manner. , 1999, American journal of respiratory cell and molecular biology.
[111] T. Welte,et al. Localization of TFF3, a new mucus-associated peptide of the human respiratory tract. , 1999, American journal of respiratory and critical care medicine.
[112] C. Epstein,et al. Goblet cell-specific expression mediated by the MUC2 mucin gene promoter in the intestine of transgenic mice. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[113] R. Bresalier,et al. Liver colonization by human colon cancer cells is reduced by antisense inhibition of MUC2 mucin synthesis. , 1999, Gastroenterology.
[114] Jacqueline Capeau,et al. Downregulation of the colon tumour-suppressor homeobox gene Cdx-2 by oncogenic ras , 1999, Oncogene.
[115] Y. Nakanuma,et al. Expression of MUC2, MUC5AC and MUC6 apomucins in carcinoma, dysplasia and non‐dysplastic epithelia of the gallbladder , 1999, Pathology international.
[116] G. Niehans,et al. The MUC6 secretory mucin gene is expressed in a wide variety of epithelial tissues , 1998, The Journal of pathology.
[117] E. Keeffe,et al. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. , 1998, The Journal of clinical investigation.
[118] J. Olsen,et al. Risk of liver and other types of cancer in patients with cirrhosis: A nationwide cohort study in Denmark , 1998, Hepatology.
[119] D. Thornton,et al. Isolation and physical characterization of the MUC7 (MG2) mucin from saliva: evidence for self-association. , 1998, The Biochemical journal.
[120] Y. Nakanuma,et al. Increased MUC6 apomucin expression is a characteristic of reactive biliary epithelium in chronic viral hepatitis , 1998, The Journal of pathology.
[121] J. Dagorn,et al. Expression of the Cdx1 and Cdx2 Homeotic Genes Leads to Reduced Malignancy in Colon Cancer-derived Cells* , 1998, The Journal of Biological Chemistry.
[122] J. van Marle,et al. MUC5B is the prominent mucin in human gallbladder and is also expressed in a subset of colonic goblet cells. , 1998, The American journal of physiology.
[123] Y. Kim,et al. Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles. , 1998, American journal of clinical pathology.
[124] Y. Kim,et al. Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction , 1998, Hepatology.
[125] B. Clement,et al. Mucin gene expression in biliary epithelial cells. , 1997, Journal of hepatology.
[126] B. Macpherson,et al. Ground squirrel model for cholelithiasis: Role of epithelial glycoproteins , 1997, Microscopy research and technique.
[127] Jan Mollenhauer,et al. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3–26.1 is deleted in malignant brain tumours , 1997, Nature Genetics.
[128] I. van Seuningen,et al. Genomic Organization of the 3′ Region of the Human Mucin GeneMUC5B * , 1997, The Journal of Biological Chemistry.
[129] B. Paigen,et al. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: physical-chemistry of gallbladder bile. , 1997, Journal of lipid research.
[130] R. Bresalier,et al. Liver endothelial E‐selectin mediates carcinoma cell adhesion and promotes liver metastasis , 1997, International journal of cancer.
[131] N. Afdhal,et al. Molecular cloning of a major human gall bladder mucin: complete C-terminal sequence and genomic organization of MUC5B. , 1997, The Biochemical journal.
[132] E. Schlaepfer,et al. Improved In Situ Hybridization to HIV with RNA Probes Derived from PCR Products , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[133] N. Nowak,et al. Chromosomal localization of a human mucin gene (MUC8) and cloning of the cDNA corresponding to the carboxy terminus. , 1997, American journal of respiratory cell and molecular biology.
[134] S. Dooley,et al. The three human trefoil genes TFF1, TFF2, and TFF3 are located within a region of 55 kb on chromosome 21q22.3. , 1997, Genomics.
[135] N. Porchet,et al. Human Mucin Gene MUC5B, the 10.7-kb Large Central Exon Encodes Various Alternate Subdomains Resulting in a Super-repeat , 1997, The Journal of Biological Chemistry.
[136] D. Swallow,et al. Human mucin genes assigned to 11p15.5: identification and organization of a cluster of genes. , 1996, Genomics.
[137] Y. Kim,et al. Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: An immunohistochemical study , 1996, Hepatology.
[138] M. Fishman,et al. Impaired Defense of Intestinal Mucosa in Mice Lacking Intestinal Trefoil Factor , 1996, Science.
[139] P. Chambon,et al. Gastric Mucosa Abnormalities and Tumorigenesis in Mice Lacking the pS2 Trefoil Protein , 1996, Science.
[140] T. Lesuffleur,et al. Alteration in mucin gene expression and biological properties of HT29 colon cancer cell subpopulations. , 1996, European journal of cancer.
[141] Y. Nakanuma,et al. Abnormal expression of MUC1 apomucin and mature MUC1 mucin in biliary epithelial cells in various cystic liver diseases , 1996, Hepatology.
[142] H. Shizuya,et al. Cloning of contiguous genomic fragments from human chromosome 21 harbouring three trefoil peptide genes , 1996, Human Genetics.
[143] Y. Nakanuma,et al. Frequent expression of MUC1 apomucin on biliary epithelial cells of damaged small bile ducts in primary biliary cirrhosis and chronic viral hepatitis: An immunohistochemical study , 1996, Hepatology.
[144] Patricia A. Gabow,et al. PKD2, a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein , 1996, Science.
[145] R. Poulsom,et al. Molecular aspects of restitution: functions of trefoil peptides. , 1996, The Yale journal of biology and medicine.
[146] R. Poulsom,et al. The gene encoding human intestinal trefoil factor (TFF3) is located on chromosome 21q22.3 clustered with other members of the trefoil peptide family. , 1996, Genomics.
[147] T. Shows,et al. Structure and chromosomal localization of the human salivary mucin gene, MUC7. , 1996, Genomics.
[148] L. Johnson. Liver biopsy interpretation 5th ed , 1996 .
[149] W. Joba,et al. Biosynthesis and molecular architecture of gel-forming mucins: implications from an amphibian model system. , 1995, Biochemical Society transactions.
[150] R. Colombari,et al. Biliary Tumors of the Liver , 1995, Seminars in liver disease.
[151] Y. Kim,et al. Diversity of mucin genes, structure, function, and expression. , 1995, Gastroenterology.
[152] T. Terada,et al. Biliary epithelial expression of MUC1, MUC2, MUC3 and MUC5/6 apomucins during intrahepatic bile duct development and maturation. An immunohistochemical study. , 1995, The American journal of pathology.
[153] G. Young,et al. Cdx-2 homeodomain protein expression in human and rat colorectal adenoma and carcinoma. , 1995, The American journal of pathology.
[154] J. Ferlay,et al. Cancer incidence in Thailand, 1988-1991. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[155] K. Tsuneyama,et al. Hepatitic bile duct injuries in chronic hepatitis C: histopathologic and immunohistochemical studies. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[156] Y. Nakanuma,et al. Expression of Mucin core protein of mammary type in primary liver cancer , 1994, Hepatology.
[157] L. Thim,et al. Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. , 1994, The Journal of clinical investigation.
[158] Siep Thomas,et al. THE POLYCYSTIC KIDNEY-DISEASE-1 GENE ENCODES A 14-KB TRANSCRIPT AND LIES WITHIN A DUPLICATED REGION ON CHROMOSOME-16 , 1994 .
[159] T. Terada,et al. Intrahepatic cholangiocarcinomas associated with nonbiliary cirrhosis. A clinicopathologic study. , 1994, Journal of clinical gastroenterology.
[160] R. Bacallao,et al. Biology of polycystic kidney disease. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[161] T. Terada,et al. Intrahepatic peribiliary glands of humans. II. Pathological spectrum , 1994, Journal of gastroenterology and hepatology.
[162] Y. Nakanuma,et al. Neoexpression of Lewis Y antigen is a sensitive phenotypic change of the damaged intrahepatic bile ducts , 1994, Hepatology.
[163] P. Gabow. Introduction: Autosomal Dominant Polycystic Kidney Disease , 1993 .
[164] A. Biesbrock,et al. Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). , 1993, The Journal of biological chemistry.
[165] K. Imai,et al. Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma , 1993, International journal of cancer.
[166] R. Poulsom,et al. hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[167] P. Gabow,et al. Autosomal dominant polycystic kidney disease. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[168] C. Melief,et al. Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. , 1993, Journal of immunology.
[169] K. Chayama,et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis , 1993, Hepatology.
[170] Y. S. Kim,et al. Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors , 1993, Cancer.
[171] W. Kuo,et al. Human gastric mucin. Identification of a unique species by expression cloning. , 1993, The Journal of biological chemistry.
[172] V. Desmet. Congenital diseases of intrahepatic bile ducts: Variations on the theme “ductal plate malformation” , 1992, Hepatology.
[173] T. Terada,et al. Cystic dilatation of peribiliary glands in livers with adult polycystic disease and livers with solitary nonparasitic cysts: An autopsy study , 1992, Hepatology.
[174] N. Peat,et al. Structure and biology of a carcinoma-associated mucin, MUC1. , 1991, The American review of respiratory disease.
[175] R. Bast,et al. Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. , 1991, Cancer research.
[176] R. Dahiya,et al. Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. , 1991, The Journal of clinical investigation.
[177] M. Gross,et al. Assignment of human tracheobronchial mucin gene(s) to 11p15 and a tracheobronchial mucin-related sequence to chromosome 13 , 1990, Human Genetics.
[178] T. Terada,et al. ‘Metaplastic lesions’ in intrahepatic bile ducts in hepatolithiasis: A histochemical and immunohistochemical study , 1990, Journal of gastroenterology and hepatology.
[179] J. Attwood,et al. Assignment of the polymorphic intestinal mucin gene (MUC2) to chromosome 11p15 , 1990, Annals of human genetics.
[180] D. Swallow,et al. Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. , 1990, Biochemical and biophysical research communications.
[181] Ann M. Johnson,et al. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease , 1990, Hepatology.
[182] R. Lathe,et al. hSP, the domain‐duplicated homolog of pS2 protein, is co‐expressed with pS2 in stomach but not in breast carcinoma. , 1990, The EMBO journal.
[183] M. Gerber,et al. Development of intrahepatic bile ducts in humans. Immunohistochemical study using monoclonal cytokeratin antibodies. , 1989, Archives of pathology & laboratory medicine.
[184] Y. Nakanuma,et al. Expression of blood group‐related antigens in the intrahepatic biliary tree and hepatocytes in normal livers and various hepatobiliary diseases , 1989, Hepatology.
[185] P. Bhathal,et al. Morphological and immunohistochemical assessment of intrahepatic bile duct development in the rat , 1989, Journal of gastroenterology and hepatology.
[186] Y. Kim,et al. Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. , 1989, The Journal of biological chemistry.
[187] Y. Nakanuma,et al. Endocrine cells in the intrahepatic biliary tree in normal livers and hepatolithiasis. , 1989, Archives of pathology & laboratory medicine.
[188] P. van Eyken,et al. The development of the intrahepatic bile ducts in man: A keratin‐immunohistochemical study , 1988, Hepatology.
[189] J. Guest,et al. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[190] T. Terada,et al. Pathologic features of hepatolithiasis in Japan. , 1988, Human pathology.
[191] J. Brody,et al. Human neutrophil elastase releases cell surface mucins from primary cultures of hamster tracheal epithelial cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[192] J. Taylor‐Papadimitriou,et al. Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. , 1987, Cancer research.
[193] R. N. Macsween,et al. Expression of tissue polypeptide antigen (TPA) in fetal and adult liver: changes in liver disease. , 1987, Journal of clinical pathology.
[194] I. Mackay,et al. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. , 1987, Journal of immunology.
[195] R. Macsween. Pathology of the Liver , 1981 .
[196] M. Kaplan,et al. Primary Biliary Cirrhosis , 1987, The New England journal of medicine.
[197] P. Verdugo,et al. Molecular mechanism of product storage and release in mucin secretion. II. The role of extracellular Ca++. , 1986, Biorheology.
[198] T. Terada,et al. Are hepatolithiasis and cholangiocarcinoma aetiologically related? , 1985, Virchows Archiv A.
[199] N. Shiojiri. The origin of intrahepatic bile duct cells in the mouse. , 1984, Journal of embryology and experimental morphology.
[200] H. Spiro,et al. Liver Biopsy Interpretation (3rd ed.) , 1983 .
[201] Benjamin Geiger,et al. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells , 1982, Cell.
[202] W. Bodmer,et al. Monoclonal antibodies to epithelium‐specific components of the human milk fat globule membrane: Production and reaction with cells in culture , 1981, International journal of cancer.
[203] L. Agodoa,et al. Liver cysts in patients with autosomal dominant polycystic kidney disease. , 1980, The American journal of medicine.
[204] Y. Nakanuma,et al. Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis , 1979 .
[205] R. Soloway,et al. Pigment vs cholesterol cholelithiasis: Comparison of stone and bile composition , 1974, The American Journal of Digestive Diseases.
[206] P. Steiner,et al. Cholangiolocellular carcinoma of the liver , 1959, Cancer.
[207] C. Ker,et al. Hepatolithiasis in East Asia retrospective study , 2005, Digestive Diseases and Sciences.
[208] R. Bresalier,et al. Mucins and mucin binding proteins in colorectal cancer , 2004, Cancer and Metastasis Reviews.
[209] I. Gipson,et al. Differential regulation of membrane-associated mucins in the human ocular surface epithelium. , 2004, Investigative ophthalmology & visual science.
[210] D. Thornton,et al. From mucins to mucus: toward a more coherent understanding of this essential barrier. , 2004, Proceedings of the American Thoracic Society.
[211] W. Jagla,et al. Molecular medicine of TFF-peptides: from gut to brain. , 2001, Histology and histopathology.
[212] E. Keeffe,et al. The immunopathology of primary biliary cirrhosis: thoughts for the millennium. , 2000, Archivum immunologiae et therapiae experimentalis.
[213] H. Itoh,et al. Overexpression of intestinal trefoil factor in human colon carcinoma cells reduces cellular growth in vitro and in vivo. , 2000, Gastroenterology.
[214] Stanley R. Hamilton,et al. Pathology and genetics of tumours of the digestive system , 2000 .
[215] C. Tomasetto,et al. pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. , 2000, Gastroenterology.
[216] P. Sithithaworn,et al. Liver flukes and liver cancer , 1999 .
[217] Y. Nakanuma,et al. Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial cells: in situ and culture study. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[218] M. Buisine,et al. Evolutionary History of the 11p15 Human Mucin Gene Family , 1998, Journal of Molecular Evolution.
[219] 日本肝癌研究会. Classification of primary liver cancer , 1997 .
[220] N. Blin,et al. Human Trefoil Peptides: Genomic Structure in 21q22.3 and Coordinated Expression , 1996, European journal of human genetics : EJHG.
[221] V. Debailleul,et al. Characterization of the human mucin gene MUC5AC: a consensus cysteine-rich domain for 11p15 mucin genes? , 1995, The Biochemical journal.
[222] R. Playford,et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. , 1995, Gastroenterology.
[223] J. Ludwig,et al. The liver in autosomal dominant polycystic kidney disease. Implications for pathogenesis. , 1990, Archives of pathology & laboratory medicine.
[224] S. Sherlock,et al. Hepatobiliary fibropolycystic diseases. A clinical and histological review of 51 patients. , 1986, Journal of hepatology.
[225] J. Schlom,et al. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. , 1984, Hybridoma.
[226] F. Matsubara,et al. A Study of Hepatolithiasis Associated with Cholangiocarcinoma , 1978 .
[227] W. Bloom. The embryogenesis of human bile capillaries and ducts , 1926 .